164 related articles for article (PubMed ID: 34978007)
21. Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivatives.
Maryanoff BE; Costanzo MJ; Nortey SO; Greco MN; Shank RP; Schupsky JJ; Ortegon MP; Vaught JL
J Med Chem; 1998 Apr; 41(8):1315-43. PubMed ID: 9548821
[TBL] [Abstract][Full Text] [Related]
22. Cathepsin D is a good candidate for the specific release of a stable hemorphin from hemoglobin in vivo: VV-hemorphin-7.
Fruitier I; Garreau I; Piot JM
Biochem Biophys Res Commun; 1998 May; 246(3):719-24. PubMed ID: 9618278
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and anticonvulsant activity of some 2/3-benzoylaminopropionanilide derivatives.
Uysal S; Calis U; Soyer Z
Arzneimittelforschung; 2012 Jun; 62(6):295-300. PubMed ID: 22473524
[TBL] [Abstract][Full Text] [Related]
24. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
Löscher W; Hönack D
Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
[TBL] [Abstract][Full Text] [Related]
25. Anticonvulsant activity, crystal structures, and preliminary safety evaluation of N-trans-cinnamoyl derivatives of selected (un)modified aminoalkanols.
Gunia-Krzyżak A; Żesławska E; Słoczyńska K; Koczurkiewicz P; Nitek W; Żelaszczyk D; Szkaradek N; Waszkielewicz AM; Pękala E; Marona H
Eur J Med Chem; 2016 Jan; 107():26-37. PubMed ID: 26560050
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, characterization, and biological study of new synthetic opioid hemorphin-4 peptides containing sterically restricted nonnatural amino acids.
Todorov P; Georgieva S; Trapella C; Chakarov K; Tchekalarova J; Pechlivanova D; Cheshmedzhieva D; Fantinati A; Illuminati D
Arch Pharm (Weinheim); 2024 Jul; 357(7):e2400052. PubMed ID: 38578075
[TBL] [Abstract][Full Text] [Related]
27. Interaction of new VV-hemorphin-5 analogues with cell membrane models.
Vitkova V; Staneva G; Hazarosova R; Georgieva SI; Valkova I; Antonova K; Todorov P
Colloids Surf B Biointerfaces; 2022 Dec; 220():112896. PubMed ID: 36270140
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and pharmacological evaluation of N-[4-(4-(alkyl/aryl/heteroaryl)-piperazin-1-yl)-phenyl]-carbamic acid ethyl ester derivatives as novel anticonvulsant agents.
Kumari S; Mishra CB; Tiwari M
Bioorg Med Chem Lett; 2015 Mar; 25(5):1092-9. PubMed ID: 25619635
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, anticonvulsant, and antiarrhythmic properties of novel N-Mannich base and amide derivatives of β-tetralinohydantoin.
Czopek A; Byrtus H; Zagórska A; Siwek A; Kazek G; Bednarski M; Sapa J; Pawłowski M
Pharmacol Rep; 2016 Oct; 68(5):886-93. PubMed ID: 27351944
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and anticonvulsant activity of some novel 3-aryl amino/amino-4-aryl-5-imino-Delta2-1,2,4-thiadiazoline.
Gupta A; Mishra P; Kashaw SK; Jatav V; Stables JP
Eur J Med Chem; 2008 Apr; 43(4):749-54. PubMed ID: 17624632
[TBL] [Abstract][Full Text] [Related]
31. Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats.
Kitano Y; Komiyama C; Makino M; Takasuna K; Takazawa A; Sakurada S
Epilepsia; 2005 Jun; 46(6):811-8. PubMed ID: 15946322
[TBL] [Abstract][Full Text] [Related]
32. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models.
Löscher W; Hönack D; Fassbender CP; Nolting B
Epilepsy Res; 1991 Apr; 8(3):171-89. PubMed ID: 1907909
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and anticonvulsant activity of 3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide/carbothioamide analogues.
Ahsan MJ; Khalilullah H; Stables JP; Govindasamy J
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):644-50. PubMed ID: 22397394
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and anticonvulsant activity of new imidazolidindione and imidazole derivatives.
Marzouk AA; Bass AKA; Ahmed MS; Abdelhamid AA; Elshaier YAMM; Salman AMM; Aly OM
Bioorg Chem; 2020 Aug; 101():104020. PubMed ID: 32599366
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, physicochemical, and anticonvulsant properties of new N-Mannich bases derived from pyrrolidine-2,5-dione and its 3-methyl analog.
Rybka S; Obniska J; Rapacz A; Filipek B; Kamiński K
Arch Pharm (Weinheim); 2014 Oct; 347(10):768-76. PubMed ID: 25139813
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the anticonvulsant effect of novel melatonin derivatives in the intravenous pentylenetetrazol seizure test in mice.
Tchekalarova J; Angelova VT; Todorova N; Andreeva-Gateva P; Rangelov M
Eur J Pharmacol; 2019 Nov; 863():172684. PubMed ID: 31545983
[TBL] [Abstract][Full Text] [Related]
37. The effect of N-substituted alkyl groups on anticonvulsant activities of N-Cbz-alpha-amino-N-alkylglutarimides.
Lee J; Son K; Kim M; Jung G; Choi J; Lee ES; Park M
Arch Pharm Res; 1999 Oct; 22(5):491-5. PubMed ID: 10549577
[TBL] [Abstract][Full Text] [Related]
38. VV-hemorphin-7 and LVV-hemorphin-7 released during in vitro peptic hemoglobin hydrolysis are morphinomimetic peptides.
Garreau I; Zhao Q; Pejoan C; Cupo A; Piot JM
Neuropeptides; 1995 Apr; 28(4):243-50. PubMed ID: 7596489
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and anticonvulsant activity of some new dioxolane derivatives.
Ozkanli F; Güney A; Caliş U; Uzbay T
Arzneimittelforschung; 2003; 53(11):758-62. PubMed ID: 14677370
[TBL] [Abstract][Full Text] [Related]
40. Anticonvulsant 1-phenylcycloalkylamines: two analogues with low motor toxicity when orally administered.
Blake PA; Yamaguchi S; Thurkauf A; Rogawski MA
Epilepsia; 1992; 33(1):188-94. PubMed ID: 1531130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
